Autologous blood injection (ABI) for patients with chronic plantar fasciitis has been promoted as an approach to improve outcomes over standard dry-needling approaches. The purpose of this trial was to investigate if there are improved outcomes following an ultrasonography-guided ABI compared to dry needling alone for patients with chronic plantar fasciitis.
Methods:
A double-blinded (participant-blinded and observer-blinded) RCT within a single clinic enrolled 90 patients with symptoms of plantar fasciitis that had failed to improve with a minimum of 3 months of rehabilitation. The mean age was 49.5±8.9 years, 67% were female, and the mean symptom duration was 40.0±28.2 months (range: 8 months–10 years). Participants were randomized to receive ABI or an identical dry-needle fenestration-procedure without coadministration of autologous blood. All participants received identical structured rehabilitation and were followed up at 2, 6, 12, and 26 weeks. Outcome measures included local foot pain, validated foot patient-reported outcome measures (Foot Function Index–revised, Manchester-Oxford Foot Questionnaire, Foot and Ankle Ability Measure), measures of general function and “ability” (EuroQol [EQ]-5D-5L, Oswestry Disability Index), specific measures of activity (International Physical Activity Questionnaire), sleep (Pittsburgh Sleep Quality Index), and mood (Hospital Anxiety and Depression Scale).
Results:
There were no significant between-group differences seen at any time-point studied. There were a number of statistically significant within-group improvements for local foot pain and function in both groups comparing baseline/follow-up data. Overall, levels of pain improved by 25% by 6 weeks and by 50% at 6 months. There were improvements in some generalized function markers. Activity rates did not change, demonstrating that improvements in pain did not necessarily influence physical activity.
Conclusion:
Coadministration of 3 mL of autologous blood had no additional effect compared to a dry-needling procedure alone for patients with chronic plantar fasciitis.
Level of Evidence:
Level I, double-blinded randomized controlled trial.
AbbasianMBaghbaniSBarangiS, et al. Outcomes of ultrasound-guided gastrocnemius injection with botulinum toxin for chronic plantar fasciitis. Foot Ankle Int. 2020;41(1):63-68. doi: 10.1177/1071100719875220.
2.
Acosta-OlivoCElizondo-RodriguezJLopez-CavazosRVilchez-CavazosFSimental-MendiaMMendoza-LemusO.Plantar fasciitis—a comparison of treatment with intralesional steroids versus platelet-rich plasma. J Am Podiatr Med Assoc. 2017;107(6):490-496. doi: 10.7547/15-125.
3.
AfsarSSKhanAIdreesM.Comparison of autologous blood injection and corticosteroid injection in treatment of plantar fasciitis, randomized controlled trial. Pak J Surg. 2015;31(4):238-241.
Budiman-MakEConradKStuckRMattersM.Theoretical model and Rasch analysis to develop a revised Foot Function Index. Foot Ankle Int. 2006;27(7):519-527. doi: 10.1177/107110070602700707.
CarpenterJSAndrykowskiMA.Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998;45(1):5-13. doi: 10.1016/S0022-3999(97)00298-5.
8.
ColemanKJNgorEReynoldsK, et al. Initial validation of an exercise “vital sign” in electronic medical records. Med Sci Sports Exerc. 2012;44(11):2071-2076.
9.
CraigCLMarshallALSjostromM.International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395.
10.
DawsonJBollerIDollH, et al. Responsiveness of the Manchester–Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. J Bone Joint Surg Br. 2012;94 (2):215-221. doi: 10.1302/0301-620x.94b2.27634.
11.
DawsonJDollHCoffeyJJenkinsonC.Responsiveness and minimally important change for the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS and SF-36 assessments following surgery for hallux valgus. Osteoarthritis Cartilage. 2007;15(8):918-931. doi: http://dx.doi.org/10.1016/j.joca.2007.02.003.
12.
DiGiovanniBFNawoczenskiDALintalME, et al. Tissue-specific plantar fascia-stretching exercise enhances outcomes in patients with chronic heel pain: a prospective, randomized study. J Bone Joint Surg Am. 2003;85(7):1270-1277.
13.
Elizondo-RodríguezJSimental-MendíaMPeña-MartínezVVilchez-CavazosFTamez-MataYAcosta-OlivoC.Comparison of botulinum toxin A, corticosteroid, and anesthetic injection for plantar fasciitis. Foot Ankle Int. 2021;42(3):305-313. doi: 10.1177/1071100720961093.
14.
ErdenTTokerBCengizOInceBAsciSToprakA.Outcome of corticosteroid injections, extracorporeal shock wave therapy, and radiofrequency thermal lesioning for chronic plantar fasciitis. Foot Ankle Int. 2021;42(1):69-75. doi: 10.1177/1071100720949469.
15.
HerdmanMGudexCLloydA, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-1736.
16.
IrvingDBCookJLYoungMAMenzHB.Impact of chronic plantar heel pain on health-related quality of life. J Am Podiatr Med Assoc. 2008;98(4):283-289. doi: 10.7547/0980283.
17.
JainKMurphyPNCloughTM.Platelet rich plasma versus corticosteroid injection for plantar fasciitis: a comparative study. Foot. 2015;25(4):235-237. doi: https://doi.org/10.1016/j.foot.2015.08.006.
18.
JainSKSuprashantKKumarSYadavAKearnsSR.Comparison of plantar fasciitis injected with platelet-rich plasma vs corticosteroids. Foot Ankle Int. 2018;39(7):780-786. doi: 10.1177/1071100718762406.
19.
JanssenMFPickardASGolickiD, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717-1727.
20.
JespersenAAmrisKBliddalH, et al. Is neuropathic pain underdiagnosed in musculoskeletal pain conditions? The Danish PainDETECTive study. Curr Med Res Opin. 2010;26(8):2041-2045. doi: 10.1185/03007995.2010.502748.
21.
KadamRVijaySChhallaniAPandhareSGuptaASinghRS.Efficacy of platelet rich plasma injection in treatment of plantar fasciitis. Int J Res Orthop. 2017;3(3):451-455. doi: 10.18203/issn.2455-4510.IntJResOrthop20171536.
22.
KarimzadehARaeissadatSAErfani FamSSedighipourLBabaei-GhazaniA.Autologous whole blood versus corticosteroid local injection in treatment of plantar fasciitis: a randomized, controlled multicenter clinical trial. Clin Rheumatol. 2017;36(3):661-669. doi: 10.1007/s10067-016-3484-6.
23.
KohlHW3rdCraigCLLambertEV, et al. The pandemic of physical inactivity: global action for public health. Lancet. 2012;380(9838):294-305. doi: 10.1016/S0140-6736(12)60898-8.
24.
KumarVMillarTMurphyPNCloughT.The treatment of intractable plantar fasciitis with platelet-rich plasma injection. Foot. 2013;23(2):74-77. doi: https://doi.org/10.1016/j.foot.2013.06.002.
25.
LandorfKBRadfordJA.Minimal important difference: values for the Foot Health Status Questionnaire, Foot Function Index and Visual Analogue Scale. Foot. 2008;18(1):15-19. doi: http://dx.doi.org/10.1016/j.foot.2007.06.006.
26.
LeeIMShiromaEJLobeloFPuskaPBlairSNKatzmarzykPT.Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219-229. doi: 10.1016/S0140-6736(12)61031-9.
27.
LeeTGAhmadTS.Intralesional autologous blood injection compared to corticosteroid injection for treatment of chronic plantar fasciitis. A prospective, randomized, controlled trial. Foot Ankle Int. 2007;28(9):984-990. doi: 10.3113/FAI.2007.0984.
28.
LimSSVosTFlaxmanAD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-2260. doi: 10.1016/S0140-6736(12)61766-8.
29.
MahindraPYaminMSelhiHSSinglaSSoniA.Chronic plantar fasciitis: effect of platelet-rich plasma, corticosteroid, and placebo. Orthopedics. 2014;39(2):e285-e289. doi: 10.3928/01477447-20160222-01.
30.
MartinRLIrrgangJJBurdettRGContiSFSwearingenJMV. Evidence of validity for the Foot and Ankle Ability Measure (FAAM). Foot Ankle Int. 2005;26(11):968-983. doi: 10.1177/107110070502601113.
31.
MartinelliNMarinozziACarnìSTrovatoUBianchiADenaroV.Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop. 2013;37(5):839-842. doi: 10.1007/s00264-012-1741-0.
32.
MenzHBJordanKPRoddyECroftPR.Characteristics of primary care consultations for musculoskeletal foot and ankle problems in the UK. Rheumatology (Oxford, England)2010;49(7):1391-8. doi: 10.1093/rheumatology/keq092.
33.
Mohseni-BandpeiMANakhaeeMMousaviMEShakouriradASafariMRVahab KashaniR.Application of ultrasound in the assessment of plantar fascia in patients with plantar fasciitis: a systematic review. Ultrasound Med Biol. 2014;40(8):1737-1754. doi: http://dx.doi.org/10.1016/j.ultrasmedbio.2014.03.001.
34.
MonteagudoMAlbornozPMdGutierrezBTabuencaJÁlvarezI.Plantar fasciopathy: a current concepts review. EFORT Open Rev. 2018;3(8):485-493. doi: 10.1302/2058-5241.3.170080.
35.
MorleyDJenkinsonCDollH, et al. The Manchester–Oxford Foot Questionnaire (MOXFQ): development and validation of a summary index score. Bone Joint Res. 2013;2(4):66-69. doi: 10.1302/2046-3758.24.2000147.
36.
NahinRL.Prevalence and pharmaceutical treatment of plantar fasciitis in United States adults. J Pain. 2018;19(8):885-896. doi: 10.1016/j.jpain.2018.03.003.
37.
NeblettRCohenHChoiY, et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14(5):438-445. doi: https://doi.org/10.1016/j.jpain.2012.11.012.
38.
NeufeldSKCerratoR.Plantar fasciitis: evaluation and treatment. J Am Acad Orthop Surg. 2008;16(6):338-346.
RajasekaranSFinnoffJT.Plantar fasciopathy: a clinical review. Curr Phys Med Rehabil Rep. 2015;3(1):67-76. doi: 10.1007/s40141-014-0069-7.
41.
RiddleDLSchappertSM.Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis: a national study of medical doctors. Foot Ankle Int. 2004;25(5):303-310. doi: 10.1177/107110070402500505.
42.
SallisR.Developing healthcare systems to support exercise: exercise as the fifth vital sign. Br J Sports Med. 2011;45(6):473-474. doi: 10.1136/bjsm.2010.083469.
43.
ScarboroughPBhatnagarPWickramasingheKKAllenderSFosterCRaynerM.The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006–07 NHS costs. J Public Health. 2011;33(4):527-535. doi: 10.1093/pubmed/fdr033.
44.
SherpyNAHammadMAHagrassHASamirHAbu-ElMaatySEMortadaMA.Local injection of autologous platelet rich plasma compared to corticosteroid treatment of chronic plantar fasciitis patients: a clinical and ultrasonographic follow-up study. Egypt Rheumatol. 2016;38(3):247-252. doi: https://doi.org/10.1016/j.ejr.2015.09.008.
45.
SmarrKLKeeferAL.Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res. 2011;63(S11):S454-S466. doi: 10.1002/acr.20556.
46.
SmithMTPerlisMLSmithMSGilesDECarmodyTP.Sleep quality and presleep arousal in chronic pain. J Behav Med. 2000;23(1):1-13. doi: 10.1023/A:1005444719169.
47.
SnaithRPZigmondAS.The Hospital Anxiety and Depression Scale Manual. Nfer-Nelson; 1994.
48.
SooHooNFSamimiDBVyasRMBotzlerT.Evaluation of the validity of the Foot Function Index in measuring outcomes in patients with foot and ankle disorders. Foot Ankle Int. 2006;27(1):38-42. doi: 10.1177/107110070602700107.
49.
ThoraATiwariABhatnagarNMohindraM.Efficacy of platelet rich plasma in comparison to steroid for the management of chronic plantar fasciitis. Int J Res Orthop. 2018;4(3). doi: 10.18203/issn.2455-4510.IntJResOrthop20181671 .
50.
TiwariMBhargavaR.Platelet rich plasma therapy: a comparative effective therapy with promising results in plantar fasciitis. J Clin Orthop Trauma. 2013;4(1):31-35. doi: https://doi.org/10.1016/j.jcot.2013.01.008.
51.
VahdatpourBKianimehrLAhrarMH.Autologous platelet-rich plasma compared with whole blood for the treatment of chronic plantar fasciitis; a comparative clinical trial. Adv Biomed Res. 2016;5(84). doi: 10.4103/2277-9175.182215.
52.
WheelerP.Autologous blood injections for chronic plantar fasciitis – a pilot case-series study shows promising results. Int Musculoskelet Med. 2013;35(1):3-7. doi: 10.1179/1753615413Y.0000000015.
53.
WheelerPBoydKShiptonM.Surgery for patients with recalcitrant plantar fasciitis: good results at short-, medium-, and long-term follow-up. Orthop J Sports Med. 2014;2(3). doi: 10.1177/2325967114527901.
54.
WheelerPC.The role of autologous blood injections in the treatment for patients with chronic plantar fasciitis – a case series and longer term follow-up. Int Musculoskelet Med. 2015;37(2):47-53.
55.
WheelerPC.Neuropathic pain may be common in chronic lower limb tendinopathy; a prospective cohort study. Br J Pain. 2017;11(1):16-22. doi: 10.1177/2049463716680560.
56.
WheelerPC.Up to a quarter of patients with certain chronic recalcitrant tendinopathies may have Central Sensitisation – a prospective cohort of more than 300 patients. Br J Pain. 2019;13(3):137-144. doi: 10.1177/2049463718800352.
57.
WheelerPCTattersallC.Extracorporeal shockwave therapy plus rehabilitation for patients with chronic plantar fasciitis might reduce pain and improve function but still not lead to increased activity: a case-series study with multiple outcome measures. J Foot Ankle Surg. 2018;57(2):339-345. doi: 10.1053/j.jfas.2017.07.001.
58.
WilsonJJLeeKSMillerATWangS.Platelet-rich plasma for the treatment of chronic plantar fasciopathy in adults:a case series. Foot Ankle Spec. 2014;7(1):61-67. doi: 10.1177/1938640013509671.
59.
XuDJiangWHuangD, et al. Comparison between extracorporeal shock wave therapy and local corticosteroid injection for plantar fasciitis. Foot Ankle Int. 2020;41(2):200-205. doi: 10.1177/1071100719891111.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
